arrow
Back
M

Michael G. Nanna

Yale School of Medicine

25H-index
198Paper Count
2.3KCitation Count
Published Papers 86
Publication Date
Statin discontinuation in older adults: changing the conversation, not the default
err2026-08-11
err0
errOAAI
errShefa Arya Nezhad; Parvaneh Rastgou; Michael G Nanna
errShare
errSave
Outcomes After Percutaneous Coronary Intervention for Chronic Coronary Disease in Adults ≥ 75 versus < 75 Years
err2026-04-17
err0
PREAI
errZafer Akman; Dae Yong Park; Sumit Sohal; Darrick K. Li; Jiun-Ruey Hu; Laura-M Romero; Raiza Rossi; Armin Nouri; Shefa Arya Nezhad; Mohammad Al Mouslmani; Greta Campbell; Ajar Kochar; Jennifer Frampton; Abdulla A. Damluji; Michael G. Nanna
errShare
errSave
Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real-World: Results From the SCORE—Clinical ASCVD Study
err2026-03-26
err0
errOAAI
errMichael G. Nanna; Carlos Mena-Hurtado; Victoria Divino; Zhenxiang Zhao; Yan Chen; Joanna Boland; Jinlin Song; Andrea Traina; Kerem Ozer; Filip K. Knop; Kim G. Smolderen
errShare
errSave
Antiplatelet Resumption Timing in Post-Percutaneous Coronary Intervention Gastrointestinal Bleeding
err2026-03-19
err0
PREAI
errDarrick K. Li; Yuan Pu; Yihang Liu; Kisung You; Michael G. Nanna; Alyssa Harris; Joseph J. Y. Sung; Loren Laine; Dennis L. Shung
errShare
errSave
Lipid-Lowering Therapies and Cognition in Older Adults: A Narrative Review and Clinical Considerations
err2025-12-16
err0
PREAI
errRaiza Rossi; Armin Nouri; Zafer Akman; Shefa Arya Nezhad; Abdulla A. Damluji; Michael G. Nanna
errShare
errSave
Frailty in Cardiovascular Disease
errJACC
IF0
err2025-12-03
err0
PREAI
errAbdulla A. Damluji; Michael G. Nanna; Venu Menon
errShare
errSave
Optimal Management of HFpEF in Very Old Patients
err2025-12-01
err0
PREAI
errAbdulla A. Damluji; Michael G. Nanna; Michael W. Rich
errShare
errSave
The Convergence of Aging and Cardiovascular Disease
err2025-12-01
err0
errOAAI
errNanna, Michael G.; Goyal, Parag; Damluji, Abdulla A.
errShare
errSave
errShare
errSave
Representation of Older Adults in the AHA/ACC/HFSA Guideline for the Management of Heart Failure
err2025-12-01
err0
errOAAI
errJamil, Yasser; El Ghazawi, Alaaeddine; Farhat, Kassem; Nouri, Armin; Goyal, Parag; Damluji, Abdulla A.; Nanna, Michael G.; Samsky, Marc D.
errShare
errSave
errShare
errSave
The Additive Value of FFR-CT in the Evaluation of Calcified Coronary Arteries With Coronary CT Angiography
err2025-10-01
err0
PREAI
errKyriakoulis, Ioannis; Nanna, Michael G.; Rao-Brito, Meghana; Cambi, Brian; Mazzarelli, Louis; Kokkinidis, Damianos G.
errShare
errSave
Factors associated with elevated high-sensitivity C-reactive protein levels in individuals with atherosclerotic cardiovascular disease in the USA and the UK
err2025-10-01
err1
errOAAI
errRay, Kausik K.; Reuter, Simon Bertram; Dalbeler, Aysegul; Faurby, Mads D.; Letnar, Gasper; Mathisen, Jimmi; Nanna, Michael G.; Ng, Fu Siong; Pearson-Stuttard, Jonathan; Sattar, Naveed; Thompson, Andrew; Navar, Ann Marie
errShare
errSave
In-Hospital Mortality Among Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion with and Without Malignancy
err2025-09-29
err0
errOAAI
errJu Young Bae; Dae Yong Park; Soumya Banna; Jiun-Ruey Hu; Amr Saleh; Mamas A. Mamas; Robert L. McNamara; Michael G. Nanna; John F. Setaro; Luke K. Kim; S. Elissa Altin
errShare
errSave
Lower risk of cardiovascular events in patients initiated on semaglutide 2.4 mg in the real-world: Results from the SCORE study (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity in the Real World)
err2025-09-09
err0
errOAAI
errKim G. Smolderen PhD; Carlos Mena-Hurtado MD; Zhenxiang Zhao PhD; Wojciech Michalak MSc; Mads Faurby MSc; B. Gabriel Smolarz MD; Mikhail N. Kosiborod MD; Jinlin Song PhD; Yan Chen PhD; Joanna Boland PhD; Michael G. Nanna MD
errShare
errSave
Fractional flow reserve-guided complete revascularization versus culprit-only percutaneous coronary intervention in patients with myocardial infarction: A meta-analysis of randomized controlled trials
err2025-09-01
err0
PREAI
errEzenna, Chidubem; Krishna, Mrinal Murali; Joseph, Meghna; Pereira, Vinicius; Ramesh, Prasana; Ismayl, Mahmoud; Nanna, Michael G.; Goldsweig, Andrew M.
errShare
errSave
Direct oral anticoagulants vs. warfarin for left ventricular thrombus: a meta-analysis of randomized controlled trials
err2025-09-01
err0
PREAI
errChi, Kuan-Yu; Lee, Pei-Lun; Abdullah, Ahmed; Kumar, Sriram Sunil; Ezenna, Chidubem; Romero Acero, Laura Marcela; Krishna, Mrinal Murali; Akman, Zafer; Lin, Yu-Shiuan; Damluji, Abdulla A.; Nanna, Michael G.
errShare
errSave
Global uptake of GLP-1 receptor agonists in obese, non-diabetic patients with cardiovascular disease
err2025-09-01
err0
PREAI
errChi, Kuan-Yu; Pollanen, Sara; Hu, Jiun-Ruey; Lee, Pei-Lun; Mangalesh, Sridhar; Ezenna, Chidubem; Joseph, Meghna; Krishna, Mrinal Murali; Lin, Yu-Shiuan; Romero Acero, Laura Marcela; Chang, Yu; Damluji, Abdulla A.; Nanna, Michael G.
errShare
errSave
Cover
err2025-07-26
err0
PREAI
errYasser Jamil; Abdulla A. Damluji; Michael G. Nanna
errShare
errSave
PCSK9 inhibitors and aging: Does chronological age matter?
err2025-07-09
err0
PREAI
errMohammad Al Mouslmani; Armin Nouri; Abdulla A. Damluji; Michael G. Nanna
errShare
errSave